For the year ending 2025-12-31, ACLX had -$25,427K decrease in cash & cash equivalents over the period. -$212,585K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -228,934 |
| Depreciation and amortization | 6,678 |
| Loss on disposal of property and equipment | -82 |
| Noncash operating lease expense | -38 |
| Right of use asset expensed | 0 |
| Amortization of premiums and discounts on marketable securities | 8,443 |
| Share-based compensation | 77,891 |
| Prepaid expenses and other current and non-current assets | 2,211 |
| Accounts payable and other current liabilities | 2,664 |
| Accrued liabilities | -21,437 |
| Operating lease liabilities | -1,931 |
| Contract liability to related party | -25,986 |
| Other non-current liabilities | -8,593 |
| Net cash provided by (used in) operating activities | -210,258 |
| Purchases of property and equipment | 2,327 |
| Purchases of marketable securities | 406,976 |
| Proceeds from maturities of marketable securities | 495,600 |
| Net cash provided by (used in) investing activities | 86,297 |
| Proceeds from issuance of common stock in private placement, net of transactions costs | 0 |
| Proceeds from issuance of common stock in offerings, net of issuance costs | 131,562 |
| Proceeds from exercise of stock options | 4,321 |
| Proceeds from issuance of common stock under the employee stock purchase plan | 1,303 |
| Payments under finance leases | 230 |
| Tax withholding payments related to net share settlement of restricted stock units | 38,422 |
| Net cash provided by (used in) financing activities | 98,534 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | -25,427 |
| Cash and cash equivalents and restricted cash, beginning of the year | 108,305 |
| Cash and cash equivalents and restricted cash, end of the year | 82,878 |